Holen Sie sich die Stockscreener-App
18.98
0.11%
0.02
Handel nachbörslich:
18.98
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$18.96
Offen:
$18.85
24-Stunden-Volumen:
7.94M
Relative Volume:
1.00
Marktkapitalisierung:
$9.76B
Einnahmen:
$10.89B
Nettoeinkommen (Verlust:
$-241.00M
KGV:
-71.46
EPS:
-0.2656
Netto-Cashflow:
$340.00M
1W Leistung:
-2.82%
1M Leistung:
+3.66%
6M Leistung:
-36.71%
1J Leistung:
-35.66%
1-Tages-Spanne:
$18.84
$19.22
1-Wochen-Bereich:
$18.82
$19.57
52-Wochen-Spanne:
$17.40
$37.74
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(224) 948-2000
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Vergleichen Sie BAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
18.98 | 9.75B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
579.83 | 202.94B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
196.74 | 55.73B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.55 | 39.28B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
246.67 | 35.75B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.18 | 32.78B | 0 | 0 | 0 | 0.00 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Herabstufung | Argus | Buy → Hold |
| 2025-08-04 | Herabstufung | Stifel | Buy → Hold |
| 2025-08-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-02-26 | Fortgesetzt | Goldman | Buy |
| 2025-02-24 | Hochstufung | Argus | Hold → Buy |
| 2025-02-20 | Fortgesetzt | Barclays | Overweight |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-18 | Bestätigt | Raymond James | Outperform |
| 2022-02-18 | Bestätigt | Stifel | Buy |
| 2022-02-18 | Bestätigt | UBS | Neutral |
| 2022-02-18 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
| 2022-01-07 | Fortgesetzt | Citigroup | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Herabstufung | UBS | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-09-04 | Herabstufung | Argus | Buy → Hold |
| 2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-19 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Hochstufung | Argus | Hold → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
| 2018-02-06 | Bestätigt | Citigroup | Neutral |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
Baxter International Completes Cash Tender Offers, Cuts Debt - TipRanks
Baxter International Finalizes Tender Offers Settlement - TradingView — Track All Markets
A. D. Beadell Investment Counsel Inc. Takes $892,000 Position in Baxter International Inc. $BAX - Defense World
Is Baxter International Inc. stock affected by interest rate hikesJuly 2025 Summary & Stepwise Trade Signal Guides - ulpravda.ru
Is Baxter International Inc. stock a dividend growth opportunityJuly 2025 Analyst Calls & Weekly High Conviction Ideas - ulpravda.ru
Why pension funds invest in Baxter International Inc. stockJuly 2025 Trade Ideas & Daily Stock Trend Reports - ulpravda.ru
Baxter (BAX): Reassessing Valuation as Novum Infusion Pump Class Action Lawsuits Escalate - simplywall.st
Fiduciary Alliance LLC Grows Position in Baxter International Inc. $BAX - Defense World
U.S. Intravenous Solutions Market Is Going to Boom |Baxter International Inc., ICU Medical, Inc., Braun Melsungen Ag - openPR.com
Is Baxter International Inc. stock ready for breakoutEarnings Trend Report & Accurate Intraday Trade Tips - Улправда
Baxter International Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Baxter International Inc. (BAX): A Bull Case Theory - Finviz
August 2026 Options Now Available For Baxter International (BAX) - Nasdaq
Baxter International stock: Is BAX underperforming the health care sector? - MSN
Bragar Eagel & Squire is Investigating Certain Officers and - GlobeNewswire
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Baxter International and Molina Healthcare on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Baxter International (BAX) Is Up 7.5% After Class Action Over Infusion Pump Defects Filed - simplywall.st
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Levi & Korsinsky Invites Investors to SueWallSt After Baxter International, Inc. Stock Collapse - Stockhouse
Baxter International, Inc. Sued for Securities Law - GlobeNewswire
BAX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages - GlobeNewswire
BAXTER CLASS ACTION DEADLINE 12/15: Bragar Eagel & Squire, - GlobeNewswire
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Portnoy Law Firm Announces Class Action on Behalf of Baxter International, Inc. Investors - GlobeNewswire
BAX Highlights EMR-Integrated Smart Pumps Boost Patient Safety & Care - TradingView — Track All Markets
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - Voice of Alexandria
Baxter International, Inc. (BAX) Shareholders Get Answers in Latest SueWallSt Podcast - ACCESS Newswire
Investors who lost money on Baxter International, Inc.(BAX) should contact The Gross Law Firm about pending Class ActionBAX - Finansavisen
Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity - Bioscience Association Manitoba
Cullen Capital Management LLC Grows Position in Baxter International Inc. $BAX - Defense World
The Gross Law Firm Reminds Baxter International, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025BAX - Finansavisen
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm - Morningstar
Investors in Baxter International, Inc. (BAX): Protect Your RightsContact Levi & Korsinsky Before December 15, 2025 - ACCESS Newswire
BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Class Action Alert: Levi & Korsinsky Reminds Baxter International, Inc. (BAX) Investors of December 15, 2025 Deadline - Stockhouse
BAX DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Baxter Investors Have Opportunity to Lead Class Action Lawsuit - marketscreener.com
BAX DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Baxter International, Inc. Investors to Join the Class Action Lawsuit - ACCESS Newswire
Wells Fargo & Company Issues Pessimistic Forecast for Baxter International (NYSE:BAX) Stock Price - MarketBeat
BAXTER CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Baxter Investors Have Opportunity to Lead Class Action Lawsuit - TMX Newsfile
Baxter International (BAX) Gets a Hold from Wells Fargo - The Globe and Mail
Investors in Baxter International, Inc. Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your RightsBAX - Your Wyoming Link
Deadline Soon: Baxter International, Inc. (BAX) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
Investors who lost money on Baxter International, Inc.(BAX) - GlobeNewswire
BAX DEADLINE: Faruqi & Faruqi Reminds Baxter Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 12, 2025BAX - Finansavisen
BAX Stockholders Have Opportunity to Lead Baxter International, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Wells Fargo Adjusts PT on Baxter International to $19 From $21, Maintains Equalweight Rating - marketscreener.com
Your Guide to the Baxter International, Inc. LawsuitA SueWallSt Podcast From Levi & Korsinsky - ACCESS Newswire
Wells Fargo Maintains Baxter International Inc(BAX.US) With Hold Rating, Cuts Target Price to $19 - 富途牛牛
Parkwood LLC Makes New $9.46 Million Investment in Baxter International Inc. $BAX - MarketBeat
Baxter International Stock: Is BAX Underperforming the Health Care Sector? - Barchart.com
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.01%
0.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):